| Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice M Michaud, I Martins, AQ Sukkurwala, S Adjemian, Y Ma, P Pellegatti, ... Science 334 (6062), 1573-1577, 2011 | 1393 | 2011 |
| Consensus guidelines for the detection of immunogenic cell death O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ... Oncoimmunology 3 (9), e955691, 2014 | 833 | 2014 |
| Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells Y Ma, S Adjemian, SR Mattarollo, T Yamazaki, L Aymeric, H Yang, ... Immunity 38 (4), 729-741, 2013 | 696 | 2013 |
| Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress I Martins, O Kepp, F Schlemmer, S Adjemian, M Tailler, S Shen, ... Oncogene 30 (10), 1147-1158, 2011 | 430 | 2011 |
| Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway L Zitvogel, O Kepp, L Senovilla, L Menger, N Chaput, G Kroemer Clinical Cancer Research 16 (12), 3100-3104, 2010 | 425 | 2010 |
| Cardiac glycosides exert anticancer effects by inducing immunogenic cell death L Menger, E Vacchelli, S Adjemian, I Martins, Y Ma, S Shen, T Yamazaki, ... Science translational medicine 4 (143), 143ra99-143ra99, 2012 | 419 | 2012 |
| Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy O Kepp, L Galluzzi, I Martins, F Schlemmer, S Adjemian, M Michaud, ... Cancer and Metastasis Reviews 30, 61-69, 2011 | 327 | 2011 |
| Crosstalk between ER stress and immunogenic cell death O Kepp, L Menger, E Vacchelli, C Locher, S Adjemian, T Yamazaki, ... Cytokine & growth factor reviews 24 (4), 311-318, 2013 | 211 | 2013 |
| Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer RN Ramos, Y Missolo-Koussou, Y Gerber-Ferder, CP Bromley, M Bugatti, ... Cell 185 (7), 1189-1207. e25, 2022 | 200 | 2022 |
| A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsets M Salou, F Legoux, J Gilet, A Darbois, A du Halgouet, R Alonso, W Richer, ... Journal of Experimental Medicine 216 (1), 133-151, 2019 | 171 | 2019 |
| Trial watch: Cardiac glycosides and cancer therapy L Menger, E Vacchelli, O Kepp, A Eggermont, E Tartour, L Zitvogel, ... Oncoimmunology 2 (2), e23082, 2013 | 144 | 2013 |
| Surface‐exposed calreticulin in the interaction between dying cells and phagocytes I Martins, O Kepp, L Galluzzi, L Senovilla, F Schlemmer, S Adjemian, ... Annals of the New York Academy of Sciences 1209 (1), 77-82, 2010 | 116 | 2010 |
| Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects O Kepp, L Menger, E Vacchelli, S Adjemian, I Martins, Y Ma, ... Oncoimmunology 1 (9), 1640-1642, 2012 | 114 | 2012 |
| Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death I Martins, M Michaud, AQ Sukkurwala, S Adjemian, Y Ma, S Shen, O Kepp, ... Autophagy 8 (3), 413-415, 2012 | 114 | 2012 |
| Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy A Śledzińska, L Menger, K Bergerhoff, KS Peggs, SA Quezada Molecular oncology 9 (10), 1936-1965, 2015 | 104 | 2015 |
| TALEN-mediated inactivation of PD-1 in tumor-reactive lymphocytes promotes intratumoral T-cell persistence and rejection of established tumors L Menger, A Sledzinska, K Bergerhoff, FA Vargas, J Smith, L Poirot, ... Cancer research 76 (8), 2087-2093, 2016 | 81 | 2016 |
| TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells L Menger, A Gouble, MAV Marzolini, A Pachnio, K Bergerhoff, JY Henry, ... Blood, The Journal of the American Society of Hematology 126 (26), 2781-2789, 2015 | 67 | 2015 |
| Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer E Vacchelli, L Galluzzi, V Rousseau, A Rigoni, A Tesniere, N Delahaye, ... Oncoimmunology 1 (3), 271-278, 2012 | 48 | 2012 |
| In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4+ TH1 cell response A Sutra Del Galy, S Menegatti, J Fuentealba, F Lucibello, L Perrin, J Helft, ... Science Immunology 6 (66), eabe8219, 2021 | 38 | 2021 |
| Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity M Boulch, M Cazaux, A Cuffel, MV Guerin, Z Garcia, R Alonso, F Lemaître, ... Nature Cancer 4 (7), 968-983, 2023 | 30 | 2023 |
